Received by email:

File: 2016-12-13 - AGM Results - Final.doc



CSE Symbol: IME
OTC PINK Symbol: IMEXF
Frankfurt/Stuttgart Stock Exchanges: DPD2


 
NR-2016-IME-28

 
 
Annual General Meeting Results

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care
---> for urologists in the early detection of bladder cancer through endoscopes.
    
Vancouver, B.C. and Boston, MA, December 14, 2016 - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart S
--->tock Exchanges: DPD2) (the "Company") reports that its shareholders approved all resolutions presented to them at its 
--->Annual General Meeting (the "Meeting") held on December 13, 2016.  Jim Hutchens, Robin Atlas, Steven Chan, Kenneth Dai
--->gnault and Bill Galine were elected directors for the ensuing year.  The shareholders also appointed De Visser Gray, L
--->LP as auditors of the Company.

Subsequent to the Meeting, the Board of Directors appointed Jim Hutchens as President & CEO, Jorge Avelino as Chief Fi
--->nancial Officer, and William Galine as Corporate Secretary.

About Imagin Medical  
Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Co
--->mpany believes it will radically improve the way physicians detect cancer. Imagin's initial target market is bladder c
--->ancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a gr
--->eater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive
---> imaging technology is based upon improved optical designs and advanced light sensors. Learn more at www.imaginmedical
--->.com.

ON BEHALF OF THE BOARD:
 
Jim Hutchens,
President & CEO

For further information, contact:
Bill Galine, Investor Relations
Telephone: (775) 737-3292
Email: billgaline@gmail.com

The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for t
--->he adequacy or accuracy of this news release.